Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study G Goshua, AB Pine, ML Meizlish, CH Chang, H Zhang, P Bahel, A Baluha, ... The Lancet Haematology 7 (8), e575-e582, 2020 | 1144 | 2020 |
A neutrophil activation signature predicts critical illness and mortality in COVID-19 ML Meizlish, AB Pine, JD Bishai, G Goshua, ER Nadelmann, M Simonov, ... Blood advances 5 (5), 1164-1177, 2021 | 288 | 2021 |
Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019: survival and clinical outcomes CC Price, FL Altice, Y Shyr, A Koff, L Pischel, G Goshua, MM Azar, ... Chest 158 (4), 1397-1408, 2020 | 240* | 2020 |
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection L Ma, SK Sahu, M Cano, V Kuppuswamy, J Bajwa, JN McPhatter, A Pine, ... Science immunology 6 (59), eabh2259, 2021 | 188 | 2021 |
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis ML Meizlish, G Goshua, Y Liu, R Fine, K Amin, E Chang, N DeFilippo, ... Am J Hematol 96 (4), 471-479, 2021 | 184 | 2021 |
Circulating markers of angiogenesis and endotheliopathy in COVID-19 AB Pine, ML Meizlish, G Goshua, CH Chang, H Zhang, J Bishai, P Bahel, ... Pulmonary Circulation 10 (4), 2045894020966547, 2020 | 141 | 2020 |
Porous metal revision shells for management of contained acetabular bone defects at a mean follow-up of six years: a comparison between up to 50% bleeding host bone contact and … A Sternheim, D Backstein, PRT Kuzyk, G Goshua, Y Berkovich, O Safir, ... The Journal of Bone & Joint Surgery British Volume 94 (2), 158-162, 2012 | 63 | 2012 |
Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura G Goshua, P Sinha, JE Hendrickson, C Tormey, PK Bendapudi, AI Lee Blood, The Journal of the American Society of Hematology 137 (7), 969-976, 2021 | 52 | 2021 |
Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses MO Trépanier, AY Taha, RL Mantha, FA Ciobanu, QH Zeng, ... Epilepsy research 99 (3), 225-232, 2012 | 37 | 2012 |
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 7: e575–e582 G Goshua, AB Pine, ML Meizlish, CH Chang, H Zhang, P Bahel, A Baluha, ... | 24 | 2020 |
Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura G Goshua, A Gokhale, JE Hendrickson, C Tormey, AI Lee Blood Advances 4 (3), 539-545, 2020 | 13 | 2020 |
Distributional cost-effectiveness of equity-enhancing gene therapy in sickle cell disease in the United States G Goshua, C Calhoun, S Ito, LP James, A Luviano, L Krishnamurti, ... Annals of internal medicine 176 (6), 779-787, 2023 | 12 | 2023 |
Adenovirus-based vaccines and thrombosis in pregnancy: a systematic review and meta-analysis L Pischel, KM Patel, G Goshua, SB Omer Clinical Infectious Diseases 75 (7), 1179-1186, 2022 | 11 | 2022 |
Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia G Goshua, P Sinha, N Kunst, L Pischel, AI Lee, A Cuker American journal of hematology 98 (1), 122-130, 2023 | 10 | 2023 |
Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia JP Bewersdorf, KK Patel, G Goshua, RM Shallis, NA Podoltsev, ... Blood, The Journal of the American Society of Hematology 139 (11), 1766-1770, 2022 | 9* | 2022 |
Evidence-Based Minireview: Should caplacizumab be used routinely in unselected patients with immune thrombotic thrombocytopenic purpura? G Goshua, PK Bendapudi Hematology 2022 (1), 491-494, 2022 | 6 | 2022 |
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study S Stukas, G Goshua, A Kinkade, R Grey, G Mah, CM Biggs, S Jamal, ... The Lancet Regional Health–Americas 11, 2022 | 5 | 2022 |
Immunothrombosis: a COVID‐19 concerto. G Goshua, A Butt, AI Lee British Journal of Haematology 194 (3), 2021 | 4 | 2021 |
VWF/ADAMTS13 ratios are potential markers of immunothrombotic complications in patients with COVID-19: a cross-sectional study DV Madeeva, J Christian, G Goshua, HJ Chun, AI Lee, AB Pine Blood 136, 34-35, 2020 | 4 | 2020 |
Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia JP Bewersdorf, KK Patel, G Goshua, RM Shallis, NA Podoltsev, M Stahl, ... Leukemia & lymphoma 64 (2), 454-461, 2023 | 3 | 2023 |